Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 454

1.

Practical applications of intravenous diuretic therapy in decompensated heart failure.

Cleland JG, Coletta A, Witte K.

Am J Med. 2006 Dec;119(12 Suppl 1):S26-36. Review.

PMID:
17113397
2.

Diuretics: still the mainstay of treatment.

Wang DJ, Gottlieb SS.

Crit Care Med. 2008 Jan;36(1 Suppl):S89-94. doi: 10.1097/01.CCM.0000296272.68078.6B. Review.

PMID:
18158482
3.

Mechanisms and management of diuretic resistance in congestive heart failure.

De Bruyne LK.

Postgrad Med J. 2003 May;79(931):268-71. Review.

4.

Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?

De Vecchis R, Ciccarelli A, Pucciarelli A.

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):571-4. doi: 10.2459/JCM.0b013e32833d37b9. Review.

PMID:
20588135
5.

Beyond diuretics: management of volume overload in acute heart failure syndromes.

Hill JA, Yancy CW, Abraham WT.

Am J Med. 2006 Dec;119(12 Suppl 1):S37-44. Review.

PMID:
17113399
6.

Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.

Chiong JR, Cheung RJ.

Clin Cardiol. 2010 Jun;33(6):345-52. doi: 10.1002/clc.20771. Review.

7.

Combination of loop diuretics with thiazide-type diuretics in heart failure.

Jentzer JC, DeWald TA, Hernandez AF.

J Am Coll Cardiol. 2010 Nov 2;56(19):1527-34. doi: 10.1016/j.jacc.2010.06.034. Review.

8.

Effectiveness of continuous infusions of loop diuretics for severe heart failure.

Howard PA, Dunn MI.

J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):5-10. Review.

PMID:
16645354
9.

The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.

Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC; CKI-201 and CKI-202 Investigators..

J Am Coll Cardiol. 2007 Oct 16;50(16):1551-60. Epub 2007 Oct 1.

11.
12.

Rational use of diuretics in acute decompensated heart failure.

Goebel JA, Van Bakel AB.

Curr Heart Fail Rep. 2008 Sep;5(3):153-62. Review.

PMID:
18752765
13.

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.

Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stevenson LW.

J Am Coll Cardiol. 2002 May 15;39(10):1623-9.

14.

Diuretic treatment and diuretic resistance in heart failure.

Krämer BK, Schweda F, Riegger GA.

Am J Med. 1999 Jan;106(1):90-6. Review.

PMID:
10320123
15.
16.

Approaches to diuretic therapy and electrolyte imbalance in congestive heart failure.

Cody RJ, Pickworth KK.

Cardiol Clin. 1994 Feb;12(1):37-50. Review.

PMID:
8181024
17.

[Milestones of cardiovascular therapy. V. Diuretics].

Jerie P.

Cas Lek Cesk. 2007;146(11):858-62. Review. Czech.

PMID:
18069212
18.

[Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].

Christ M, Ludwig N, Maisch B.

Herz. 2002 Mar;27(2):135-49. Review. German.

PMID:
12025459
19.

Diuretic treatment for the sodium retention of congestive heart failure.

Cody RJ, Kubo SH, Pickworth KK.

Arch Intern Med. 1994 Sep 12;154(17):1905-14. Review.

PMID:
8074594
20.

How to use diuretics in heart failure.

Volz EM, Felker GM.

Curr Treat Options Cardiovasc Med. 2009 Dec;11(6):426-32.

PMID:
19930980

Supplemental Content

Support Center